Research reveals SFTA1P acts as a tumor suppressor in non-small cell lung cancer, highlighting its regulation of TGFBR2 and signaling pathways.
The relationship of TGFBR2, PI3K−Akt signaling pathway protein expression levels and SFTA1P
No takes yet. Share an insight, caveat, or question.
Xia et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: